0.3500USD-1.96%Mkt Cap: 14.22M $P/E: —1d ago
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The …
Indicators:|
Key Statistics
Company
Market Cap14.22M $
Enterprise Value10.72M $
Revenue (TTM)477.68K $
Gross Profit331.48K $
Net Income (TTM)-41.51M $
Revenue/Share0.0210 USD
Last Price0.3500 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.83
PEG—
EV/EBITDA-0.70
EV/Revenue22.45
P/S29.77
P/B0.21
EPS (TTM)-2.45
EPS (Forward)-0.06
52W Range
0.23805% of range2.600
52W High2.600 USD
52W Low0.2380 USD
Profitability
Gross Margin76.80%
Oper. Margin-6230.80%
EBITDA Margin0.00%
Profit Margin-9618.03%
ROE-59.20%
ROA-49.31%
Growth
Revenue Growth449.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.38M $
CapEx (TTM)—
FCF Margin-170.72%
FCF Yield-5.73%
Net Debt-3.53M $
Net Debt/EBITDA0.23
Balance Sheet
Debt/Equity0.00
Current Ratio1.70
Quick Ratio1.52
Book Value/Sh1.645 USD
Cash/Share0.0870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 19, 2024
Pay DateJul 24, 2024
Splits
Last Split1:15
Split DateJun 22, 2023
Analyst Consensus
Rating—
Target (Mean)1.500 USD
Upside (mean)+328.6%
Target Range1.500 USD – 1.500 USD
# Analysts1
Ownership
Shares Out.40.63M
Float32.79M
Insiders13.31%
Institutions3.87%
Short Interest
Short Ratio2.9d
Short % Float3.10%
Short % Out.2.88%
Shares Short1.17M
Short (prev mo.)1.15M
Technical
SMA 500.3893 (-10.1%)
SMA 2000.5422 (-35.4%)
Beta—
S&P 52W Chg20.05%
Avg Vol (30d)358.48K
Avg Vol (10d)330.91K
Technical Indicators
RSI (14)38.7
MACD-0.0076
MACD Signal-0.0058
MACD Hist.-0.0019
BB Upper0.3960 USD
BB Middle0.3705 USD
BB Lower0.3451 USD
BB Width13.76%
ATR (14)0.0293 USD
Vol Ratio (20d)0.27x